Cargando…
33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465235/ http://dx.doi.org/10.1016/j.jaad.2022.06.495 |
| _version_ | 1784787751002963968 |
|---|---|
| author | Duarte Ferrera, Miguel Angel |
| author_facet | Duarte Ferrera, Miguel Angel |
| author_sort | Duarte Ferrera, Miguel Angel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9465235 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Mosby, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94652352022-09-12 33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study Duarte Ferrera, Miguel Angel J Am Acad Dermatol Article Published by Mosby, Inc. 2022-09 2022-09-12 /pmc/articles/PMC9465235/ http://dx.doi.org/10.1016/j.jaad.2022.06.495 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Duarte Ferrera, Miguel Angel 33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
| title | 33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
| title_full | 33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
| title_fullStr | 33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
| title_full_unstemmed | 33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
| title_short | 33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study |
| title_sort | 33027 telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the covid-19 pandemic: a longitudinal prospective feasibility study |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465235/ http://dx.doi.org/10.1016/j.jaad.2022.06.495 |
| work_keys_str_mv | AT duarteferreramiguelangel 33027telemedicinemanagementofsystemictherapywithisotretinoinofpatientswithmoderadotosevereacneduringthecovid19pandemicalongitudinalprospectivefeasibilitystudy |